placebo + edoxaban

This is a combination of a placebo and edoxaban. Edoxaban is an oral anticoagulant classified as a direct factor Xa inhibitor. It works by selectively inhibiting factor Xa, an essential enzyme in the coagulation cascade, thereby preventing the formation of blood clots. Edoxaban is primarily indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, as well as for treating deep vein thrombosis (DVT) and pulmonary embolism (PE) after initial therapy with a parenteral anticoagulant[1][2][6][7]. The "placebo" component refers to an inert substance with no pharmacological effect, commonly used in clinical trials to serve as a control.